Life Sciences Market Research Reports
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
20 Apr 2023  |  Asia Pacific  |  Market Outlook
Asia-Pacific Next-generation Diagnostics Outlook, 2023
The Renewed Focus on Infectious Diseases Outside COVID-9, Oncology, Cardiovascular, Diabetes, and Prenatal Care will Drive Market Growth
The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus o...
$4,950.00
Special Price $4,455.00 save 10 %
-
05 Apr 2023  |  Asia Pacific  |  Market Outlook
Asia-Pacific Pharmaceutical Industry Outlook, 2023
Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry
Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japa...
$4,950.00
Special Price $4,455.00 save 10 %
-
26 Nov 2021  |  Europe  |  Market Research
EU COVID-19 Vaccine and Therapeutics Insights, Trends, and Growth Opportunities
Future Growth Potential Driven by Capabilities and Expertise in Vaccine Manufacturing
With this research service, Frost & Sullivan’s Healthcare and Life Sciences team provides critical insights into the European Union and UK COVID-19 vaccine and therapeutics market. The report analyzes COVID-19 vaccines and therapeutics in development and delves into supply chain considerations and requirements to manage distribution. Importantly,...
$2,450.00
Special Price $1,837.50 save 25 %
-
12 Nov 2018  |  Asia Pacific  |  Market Research
Analysis of the Singapore Clinical Laboratories Market, Forecast to 2021
Laboratory Automation is Driving the Growth of the Clinical Laboratories Market in the Country
Healthcare expenditure in Singapore is expected to grow, fueled by factors such as rising incomes and a progressively aging population. Diagnostics has emerged as a way for earlier and better identification of diseases to control rising healthcare costs in Singapore. Hence, the country has become a natural choice for many global diagnostic companie...
$1,500.00
Special Price $1,125.00 save 25 %
-
23 Aug 2018  |  Europe  |  Market Research
Western European Clinical Laboratory Services Market, Forecast to 2022
Clinical Labs to Transform into Health Information Companies and Increasingly Participate in Clinical Decision Support
Diagnostics has inarguably become an integral part of healthcare system, moving from reactionary science to predictive science; playing a vital role throughout the care continuum. While rising burden of chronic diseases, drug-resistant diseases and the increasing proportion of elderly population are the organic growth drivers, the shift towards cre...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Jun 2018  |  Europe  |  Market Research
Growth Insights for European Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2022
Rise in Cases of Sepsis and Antimicrobial Resistance (AMR) Along with the Focus on Preventative Care will Drive POCT Growth Throughout the Forecast Period
The rise in infectious diseases across Europe has led to a growing need for early detection and diagnosis of infectious diseases in the region. Point-of-care testing (POCT) is a vital part of the clinical diagnostics market and is rapidly evolving into the preferred testing mode as rapid infection diagnosis results in lower antibiotic intake, fewer...
$1,500.00
Special Price $1,125.00 save 25 %
-
10 Jan 2018  |  Asia Pacific  |  Market Research
APAC Biosimilar Market, Forecast 2025
Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth
Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Ko...
$4,950.00
Special Price $3,712.50 save 25 %